Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors

DRUG2 trials

Sponsors

Feng Wang, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

Colorectal CancerColorectal Cancer Metastatic

Unknown Phase

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Not yet recruitingNCT06682247

Feng WangColorectal Cancer Metastatic

Start: 2024-11-15End: 2025-12-31Target: 200Updated: 2024-11-12

Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer

Not yet recruitingNCT06858956

Cancer Institute and Hospital, Chinese Academy of Medical SciencesColorectal Cancer

Start: 2025-03-01End: 2026-05-31Target: 200Updated: 2025-03-05